The National Health Service (NHS) in England has announced it will no longer prescribe testosterone or oestrogen to transgender patients under the age of 18, following an extensive clinical review that determined the evidence base was insufficient to justify continued use.
Professor James Palmer, a national medical director for NHS England, said:
The available evidence does not support the continued use of masculinising or feminising hormones to treat gender incongruence or dysphoria for young people under 18.
A public consultation will now commence on removing these treatments as routine interventions for minors.
